期刊文献+

益气活血降脂散合并耳穴压豆治疗非酒精性脂肪肝的疗效观察 被引量:8

Clinical observation on treating non-alcohol fatty liver with Yiqi Huoxue Jiangzhi San plus auricular pressure
下载PDF
导出
摘要 目的:观察益气活血降脂散合并耳穴压豆治疗非酒精性脂肪肝的疗效。方法:选择符合"病例纳入标准及排除标准"的200名研究对象,随机分成四组,益气活血降脂散组、耳穴压豆组、益气活血降脂散合并耳穴压豆组和西药治疗组,治疗3个疗程后根据疗效判断标准判断疗效。结果:益气活血降脂散合并耳穴压豆组50例中,临床治愈31例,占62%,好转13例,占26%,总有效率88%,且血清TC、TG全部在正常范围,B超显示肝脂肪变也较治疗前明显改善。结论:益气活血降脂散合并耳穴压豆治疗非酒精性脂肪肝具有良好的效果。 Objective:To observe clinical efficacy of Yiqi Huoxue Jiangzhi San plus auricular pressure on treating non-alcohol fatty liver. Methods:200 patients were randomly divided into four groups, including Yiqi Huoxue Jiangzhi San, auricular pressure, Yiqi Huoxue Jiangzhi San plus auricular pressure and western medicine therapy, and clinical efficacy was recorded according to the curative standard with three courses of treatment. Results:50 cases were treated by Yiqi Huoxue Jiangzhi San plus auricular pressure, 31 patients (62%) were cured, 13 patients (26%) were improved, the total efficacy was 88%, TC and TG were in the normal range, and type-B ultrasonic showed that liver fat was improved. Conclusion:Yiqi Huoxue Jiangzhi San plus auricular pressure was effective on non-alcohol fatty liver.
作者 陈训梅
出处 《中医临床研究》 2014年第16期35-37,共3页 Clinical Journal Of Chinese Medicine
关键词 益气活血降脂散 耳穴压豆 非酒精性脂肪肝 Yiqi Huoxue Jiangzhi San Auricular pressure Non-alcohol fatty liver
  • 相关文献

参考文献5

二级参考文献26

  • 1金鸣.活血化淤与抗自由基损伤[J].中草药,1993,24(5):269-272. 被引量:43
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3戚丽,路中.非酒精性脂肪肝胰岛素抵抗及血清瘦素和脂联素水平的研究[J].中国中西医结合消化杂志,2006,14(3):167-170. 被引量:5
  • 4Schwimmer JB,Behling C,Newbury R,Deutsch R,Nievergelt C,Schork NJ,Lavine JE.Histopathologyof pediatric nonalcoholic fatty liver disease[J].Hepatology,2005,42:641-649.
  • 5Marchesini G,Marzocchi R,Agostini F,Bugianesi E.Nonalcoholic fatty liver disease and the metabolicsyndrome[J].Curr Opin Lipidol,2005,16:421 -427.
  • 6Yalniz M,Bahcecioglu IH,Ataseven H,UstundagB,Ilhan F,Poyrazoglu OK,Erensoy A.Serumadipokine and ghrelin levels in nonalcoholicsteatohepatitis[J].Mediators Inflamm,2006:34295.
  • 7ShklyaevS,AslanidiG,TennantM,PrimaV,KohlbrennerE,KroutovV,Campbell -ThompsonM,Crawford J,Shek EW,Scarpace PJ,ZolotukhinS.Sustained peripheral expression of transgeneadiponectin offsets the development of dietinducedobesity in rats[J].Proc Natl Acad Sci USA,2003,100:14217-14222.
  • 8LOK AS,MCMAHON BJ.Practice Guidelines Commlittee,American Association for the Study of Liver Diseases(AASLD).Chronic hepatitis B:update of recommendations[J].Hepatology,2004,39:857-861.
  • 9FARRELL GC,GEORGE J,PAULINE MH,et al.eds.Fatty liver disease:NASH and related disorders[M].Oxford:Blackwell Publishing,2005.1-22,159-207.
  • 10American Gastroenterological Association.American Gastroenterological Association Medical Position statement:nonalcoholiic fatty liver disease[J].Gastroenterology,2002,123:1702-1704

共引文献173

同被引文献127

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部